FDA Clearance Tracker · P010012-S001
CONTAK CD SYSTEM
Last checked: Nov 20, 2026Latest source record: May 20, 2002 (this decision)Source: openFDAMethods & limitations
Decided
May 20, 2002
Approved
Time to decision
13 days
Received May 7, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010012-S001
- Device name
- CONTAK CD SYSTEM
- Applicant
- Boston Scientific Corp
- Applicant location
- St Paul, MN
- Received
- May 7, 2002
- Decided
- May 20, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P010012
Device type
- Device type
- Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY FOR THE DEVICE.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.